EU Panel Likes Biosimilar Bevacizumab, Other Cancer Agents EU Panel Likes Biosimilar Bevacizumab, Other Cancer Agents

The Committee for Medicinal Products for Human Use has issued a new list of recommendations and rejections for oncology products.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news